Stay updated on Cadonilimab+Chemoradiotherapy in Nasopharyngeal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab+Chemoradiotherapy in Nasopharyngeal Carcinoma Clinical Trial page.

Latest updates to the Cadonilimab+Chemoradiotherapy in Nasopharyngeal Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check49 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check56 days agoChange DetectedThe study on Cadonilimab and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma has been removed from the recruiting status, while a new study on the same drug in a different context has been added, now marked as 'Active, not recruiting' with a future date.SummaryDifference3%
- Check63 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference1.0%
Stay in the know with updates to Cadonilimab+Chemoradiotherapy in Nasopharyngeal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab+Chemoradiotherapy in Nasopharyngeal Carcinoma Clinical Trial page.